CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BaskhanBioPharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BaskhanBioPharma Inc
354, Wondang-ro, Wongok-myeon
Phone: +82 316922900p:+82 316922900 ANSAN, 17557  South Korea Ticker: 354390354390
Business Summary
BaskhanBio Pharma Inc is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is engaged in the manufacture and sale of antipyretic analgesic anti-inflammatory drugs, digestive system drugs, central nervous system drugs, nutritional supplements and other pharmaceuticals. In addition, the Company is engaged in the sale of medical devices and health functional foods.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023-----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Beop PyoLee 58
Internal Auditor Je HyeonPark 51 3/1/2022 3/1/2022
Director Sang JinHan 44 1/1/2020 1/1/2020
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 113 (As of 12/31/2023)
Outstanding Shares: 7,018,247 (As of 12/31/2023)
Shareholders: 368
Stock Exchange: KON
Fax Number: +82 316923737


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024